Public trial registry of the CCC-Munich

Trial Lymrit 37-05

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Lymrit 37-05
World
Full title
:

A Phase 1 Dose finding study of lutetium (177Lu)-lilotomab satetraxetan (Betalutin®) in patients with relapsed/refractory, diffuse large B-cell lymphoma, not eligible for autologous stem cell transplant

World
Responsible organization
:
Nuklearmedizin
Indications
Classification Code Description
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Phase
:
I
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Sonstige - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Christian Bogner Nuklearmedizin Magnifier